MetaADEDB 2.0 @ LMMD
Albuterol
(NDAUXUAQIAJITI-UHFFFAOYSA-N)
Structure
SMILES
OCc1cc(ccc1O)C(CNC(C)(C)C)O
Type(s)
Approved; Vet_approved
ATC code(s)
R03AC02; R03AK04; R03AK13; R03AL02; R03CC02
Molecular Formula:
C13H21NO3
Molecular Weight:
239.311
Log P:
1.6969
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
4
TPSA:
72.72
CAS Number(s):
18559-94-9; 35763-26-9
Synonym(s)
1.
Albuterol
2.
Salbutamol
3.
2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
4.
Albuterol Sulfate
5.
Proventil
6.
Sultanol
7.
Ventolin
External Link(s)
MeSHD000420
PubChem Compound2083
BindingDB25769
ChEBI2549
CHEMBLCHEMBL714
DrugBankDB01001
DrugCentral105
IUPHAR/BPS Guide to PHARMACOLOGY558
KEGGdr:D02147
Therapeutic Target DatabaseD0K5CB
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product quality issueFAERS: 3066
Canada Vigilance: 17
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 1617
Canada Vigilance: 104
Canada Vigilance
US FAERS
3No adverse eventFAERS: 1371US FAERS
4Drug dose omissionFAERS: 1242OFFSIDES
US FAERS
5AsthmaFAERS: 732
Canada Vigilance: 59

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
6OverdoseFAERS: 426
Canada Vigilance: 3
Canada Vigilance
US FAERS
7Medication ErrorFAERS: 335
Canada Vigilance: 1
Canada Vigilance
US FAERS
8PneumoniaFAERS: 312
Canada Vigilance: 9
Canada Vigilance
US FAERS
9Incorrect dose administeredFAERS: 299
Canada Vigilance: 2
Canada Vigilance
US FAERS
10WheezingFAERS: 258
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
11Pharmaceutical product complaintFAERS: 250US FAERS
12MalaiseFAERS: 245
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
13Device use errorFAERS: 236US FAERS
14DysgeusiaFAERS: 207
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
15Drug administration errorFAERS: 187US FAERS
16Poor quality device usedFAERS: 169US FAERS
17Product dose omissionFAERS: 167US FAERS
18Product container issueFAERS: 157US FAERS
19TachycardiaFAERS: 157
Canada Vigilance: 7

View details

CTD
SIDER
Canada Vigilance
US FAERS
20Circumstance or information capable of leading to medication errorFAERS: 149US FAERS
21Drug prescribing errorFAERS: 147US FAERS
22ChokingFAERS: 146
Canada Vigilance: 3
Canada Vigilance
US FAERS
23Prescribed overdoseFAERS: 145US FAERS
24BronchitisFAERS: 142
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
25TremorFAERS: 141
Canada Vigilance: 26

View details

CTD
SIDER
Canada Vigilance
US FAERS
26DizzinessFAERS: 140
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
27Chest discomfortFAERS: 135
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
28Wrong technique in product usage processFAERS: 132
Canada Vigilance: 5
Canada Vigilance
US FAERS
29HeadacheFAERS: 116
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
30AnxietyFAERS: 105
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
31Chest PainFAERS: 105
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
32PalpitationsFAERS: 104
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
33Throat irritationFAERS: 100
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
34Product use issueFAERS: 98US FAERS
35Device malfunctionFAERS: 93
Canada Vigilance: 2
Canada Vigilance
US FAERS
36NasopharyngitisFAERS: 91
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
37DysphoniaFAERS: 90
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
38Myocardial InfarctionFAERS: 87
Canada Vigilance: 3

View details

CTD
Canada Vigilance
US FAERS
39NauseaFAERS: 77
Canada Vigilance: 9
Canada Vigilance
OFFSIDES
SIDER
US FAERS
40HypersensitivityFAERS: 76
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
41Oropharyngeal painFAERS: 74
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
42VomitingFAERS: 72
Canada Vigilance: 5
8285977CTD
SIDER
Canada Vigilance
US FAERS
43PainFAERS: 71
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
44Productive CoughFAERS: 71
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
45Adverse eventFAERS: 70OFFSIDES
US FAERS
46Feeling abnormalFAERS: 70SIDER
US FAERS
47FatigueFAERS: 68
Canada Vigilance: 3
3769383CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
48ArthritisFAERS: 67US FAERS
49Expired product administeredFAERS: 64
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Product taste abnormalFAERS: 64
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Product use in unapproved indicationFAERS: 59US FAERS
52Drug effect incompleteFAERS: 58US FAERS
53Cerebrovascular accidentFAERS: 56
Canada Vigilance: 2
Canada Vigilance
US FAERS
54Inappropriate schedule of drug administrationFAERS: 56US FAERS
55InfluenzaFAERS: 54
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
56AstheniaFAERS: 53
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
57Diabetes MellitusFAERS: 53
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
58SinusitisFAERS: 53
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
59BronchospasmFAERS: 52
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
60Wrong technique in device usage processFAERS: 52US FAERS
61NervousnessFAERS: 51
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
62Unevaluable eventFAERS: 51US FAERS
63CataractFAERS: 50OFFSIDES
US FAERS
64Incorrect route of drug administrationFAERS: 50US FAERS
65Feeling jitteryFAERS: 47US FAERS
66Respiratory FailureFAERS: 44
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
67Atrial FibrillationFAERS: 42
Canada Vigilance: 1
2308690
2394158
2527421
CTD
SIDER
Canada Vigilance
US FAERS
68Blood count abnormalFAERS: 42
Canada Vigilance: 3
Canada Vigilance
US FAERS
69Metabolic acidosisFAERS: 42SIDER
US FAERS
70Product substitution issueFAERS: 41
Canada Vigilance: 20
Canada Vigilance
US FAERS
71RetchingFAERS: 41SIDER
US FAERS
72UrticariaFAERS: 41
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
73Accidental overdoseFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
74Intentional product use issueFAERS: 40US FAERS
75Thermal burnFAERS: 40US FAERS
76Accidental exposure to productFAERS: 39US FAERS
77Extra dose administeredFAERS: 39US FAERS
78Lower respiratory tract infectionFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
79Respiratory distressFAERS: 39US FAERS
80Intentional drug misuseFAERS: 38OFFSIDES
US FAERS
81Memory impairmentFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Product complaintFAERS: 37
Canada Vigilance: 15
Canada Vigilance
US FAERS
83AgitationFAERS: 36
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
84Inhalation TherapyFAERS: 36US FAERS
85Intentional product misuseFAERS: 35US FAERS
86ErythemaFAERS: 34
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
87Foreign body aspirationFAERS: 34US FAERS
88HyperventilationFAERS: 34SIDER
US FAERS
89Product packaging quantity issueFAERS: 33US FAERS
90Pulmonary congestionFAERS: 33
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
91Loss of personal independence in daily activitiesFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
92Visual ImpairmentFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
93Wrong technique in drug usage processFAERS: 31US FAERS
94Poor quality drug administeredFAERS: 30US FAERS
95Expired drug administeredFAERS: 29US FAERS
96Burning sensationFAERS: 28US FAERS
97PneumothoraxFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Drug abuseFAERS: 26US FAERS
99PruritusFAERS: 26
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
100Acute myocardial infarctionFAERS: 25US FAERS
101Macular degenerationFAERS: 25US FAERS
102Abdominal discomfortFAERS: 24
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
103AphoniaFAERS: 24OFFSIDES
US FAERS
104ArthralgiaFAERS: 23SIDER
US FAERS
105Back PainFAERS: 23SIDER
US FAERS
106BlindnessFAERS: 23US FAERS
107InfectionFAERS: 23
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
108Respiratory arrestFAERS: 23US FAERS
109Blood glucose increasedFAERS: 22US FAERS
110Device FailureFAERS: 22US FAERS
111Increased upper airway secretionFAERS: 22OFFSIDES
US FAERS
112SyncopeFAERS: 22
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
113CyanosisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
114Drug DependenceFAERS: 21US FAERS
115Drug administered at inappropriate siteFAERS: 21US FAERS
116Poor quality product administeredFAERS: 21US FAERS
117Therapeutic product effect incompleteFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
118Incorrect dose administered by deviceFAERS: 20US FAERS
119LaryngitisFAERS: 20SIDER
US FAERS
120Product cleaning inadequateFAERS: 20US FAERS
121StressFAERS: 20OFFSIDES
US FAERS
122Cardiac ArrestFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
123DementiaFAERS: 19US FAERS
124DisabilityFAERS: 19US FAERS
125EpistaxisFAERS: 19SIDER
US FAERS
126General physical health deteriorationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Incorrect drug administration rateFAERS: 19US FAERS
128Oral painFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
129Pharyngolaryngeal PainFAERS: 19OFFSIDES
US FAERS
130Supraventricular tachycardiaFAERS: 19OFFSIDES
SIDER
US FAERS
131GlaucomaFAERS: 18US FAERS
132Joint injuryFAERS: 18US FAERS
133Secretion dischargeFAERS: 18US FAERS
134Weight decreasedFAERS: 18US FAERS
135Abdominal PainFAERS: 17OFFSIDES
SIDER
US FAERS
136Angina PectorisFAERS: 176811006CTD
SIDER
US FAERS
137ChillsFAERS: 17
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
138Drug administered to patient of inappropriate ageFAERS: 17US FAERS
139Emotional distressFAERS: 17OFFSIDES
SIDER
US FAERS
140HypotensionFAERS: 174843699
12970051
CTD
SIDER
US FAERS
141HypoxiaFAERS: 17OFFSIDES
US FAERS
142AmnesiaFAERS: 16OFFSIDES
US FAERS
143DiscomfortFAERS: 16SIDER
US FAERS
144DisorientationFAERS: 16US FAERS
145OsteoporosisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
146AgeusiaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Choking sensationFAERS: 15OFFSIDES
US FAERS
148Drug effect delayedFAERS: 15US FAERS
149Product lot number issueFAERS: 15US FAERS
150Toxicity to various agentsFAERS: 15US FAERS
151Urinary tract infectionFAERS: 15SIDER
US FAERS
152AngioedemaFAERS: 146476995CTD
SIDER
US FAERS
153ConstipationFAERS: 14SIDER
US FAERS
154CryingFAERS: 14US FAERS
155Device defectiveFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Drug exposure during pregnancyFAERS: 14US FAERS
157Sinus TachycardiaFAERS: 14US FAERS
158Suicide attemptFAERS: 14US FAERS
159Accidental exposureFAERS: 13US FAERS
160Drug dispensing errorFAERS: 13US FAERS
161DysuriaFAERS: 13OFFSIDES
SIDER
US FAERS
162FibromyalgiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
163Middle insomniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
164PresyncopeFAERS: 13US FAERS
165Product availability issueFAERS: 13US FAERS
166Respiratory tract congestionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
167SneezingFAERS: 13US FAERS
168ThrombosisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
169AlopeciaFAERS: 12US FAERS
170ArthropathyFAERS: 12US FAERS
171Back disorderFAERS: 12US FAERS
172DeafnessFAERS: 12OFFSIDES
US FAERS
173DehydrationFAERS: 12OFFSIDES
US FAERS
174Depressed Level of ConsciousnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Dose calculation errorFAERS: 12US FAERS
176Drug screen positiveFAERS: 12US FAERS
177Eye irritationFAERS: 12US FAERS
178Nasal PolypsFAERS: 12
Canada Vigilance: 5
Canada Vigilance
US FAERS
179ShockFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
180StomatitisFAERS: 12SIDER
US FAERS
181Urinary RetentionFAERS: 12US FAERS
182AsphyxiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
183Blood cholesterol increasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
184Blood potassium decreasedFAERS: 11US FAERS
185DependenceFAERS: 11US FAERS
186Eosinophilic granulomatosis with polyangiitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Lip swellingFAERS: 11US FAERS
188Product physical issueFAERS: 11
Canada Vigilance: 5
Canada Vigilance
US FAERS
189Product storage errorFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
190SomnolenceFAERS: 11SIDER
US FAERS
191Therapeutic response unexpected with drug substitutionFAERS: 11US FAERS
192Accidental underdoseFAERS: 10US FAERS
193Acute respiratory failureFAERS: 10OFFSIDES
US FAERS
194AngerFAERS: 10OFFSIDES
US FAERS
195Chronic sinusitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
196Incorrect drug administration durationFAERS: 10US FAERS
197Incorrect product storageFAERS: 10US FAERS
198Peripheral swellingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
199Pulmonary EmbolismFAERS: 10US FAERS
200Rheumatoid ArthritisFAERS: 10US FAERS
201VertigoFAERS: 10SIDER
US FAERS
202AbasiaFAERS: 9OFFSIDES
US FAERS
203Activities of daily living impairedFAERS: 9US FAERS
204Ankle FractureFAERS: 9US FAERS
205Coronary Artery DiseaseFAERS: 96706438CTD
US FAERS
206Eye painFAERS: 9US FAERS
207Increased bronchial secretionFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
208Musculoskeletal PainFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
209MyalgiaFAERS: 9SIDER
US FAERS
210PallorFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
211Poor quality sleepFAERS: 9US FAERS
212RestlessnessFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
213SwellingFAERS: 9US FAERS
214Throat cancerFAERS: 9US FAERS
215TinnitusFAERS: 9OFFSIDES
SIDER
US FAERS
216Apparent deathFAERS: 8US FAERS
217Atrial FlutterFAERS: 89166355CTD
US FAERS
218Breath alcohol test positiveFAERS: 8US FAERS
219Cold sweatFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
220DiverticulitisFAERS: 8US FAERS
221FlushingFAERS: 8
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
222GoutFAERS: 8US FAERS
223Impaired work abilityFAERS: 8OFFSIDES
US FAERS
224LeukocytosisFAERS: 8US FAERS
225Mental impairmentFAERS: 8US FAERS
226Therapeutic product ineffectiveFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
227Therapy changeFAERS: 8US FAERS
228CellulitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
229CholelithiasisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Device breakageFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Device ineffectiveFAERS: 7US FAERS
232Device occlusionFAERS: 7US FAERS
233Drug ineffective for unapproved indicationFAERS: 7US FAERS
234Euphoric moodFAERS: 7SIDER
US FAERS
235Feeling ColdFAERS: 7US FAERS
236Food AllergyFAERS: 7US FAERS
237Foreign body in respiratory tractFAERS: 7US FAERS
238Foreign body traumaFAERS: 7US FAERS
239Frustration tolerance decreasedFAERS: 7US FAERS
240Inability to afford medicationFAERS: 7US FAERS
241Incorrect dose administered by productFAERS: 7US FAERS
242Incorrect route of product administrationFAERS: 7US FAERS
243Irritable Bowel SyndromeFAERS: 7US FAERS
244Joint swellingFAERS: 7US FAERS
245Medical device complicationFAERS: 7US FAERS
246Musculoskeletal chest painFAERS: 7US FAERS
247Musculoskeletal discomfortFAERS: 7SIDER
US FAERS
248Musculoskeletal stiffnessFAERS: 7OFFSIDES
US FAERS
249PleurisyFAERS: 7US FAERS
250Product label issueFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
251Pulmonary HypertensionFAERS: 7US FAERS
252Respiratory tract irritationFAERS: 7US FAERS
253TachyarrhythmiaFAERS: 7US FAERS
254Ventricular FibrillationFAERS: 7US FAERS
255Alcohol test false positiveFAERS: 6US FAERS
256Anaphylactic shockFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
257Blood sodium decreasedFAERS: 6US FAERS
258Bronchial ObstructionFAERS: 6US FAERS
259BronchiectasisFAERS: 6US FAERS
260Carpal Tunnel SyndromeFAERS: 6US FAERS
261Cataract operationFAERS: 6US FAERS
262Depressed moodFAERS: 6US FAERS
263Feeling of body temperature changeFAERS: 6US FAERS
264HypothyroidismFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
265LacerationFAERS: 6US FAERS
266LymphadenopathyFAERS: 6SIDER
US FAERS
267Neck PainFAERS: 6US FAERS
268PharyngitisFAERS: 6SIDER
US FAERS
269Physical product label issueFAERS: 6US FAERS
270Pleuritic painFAERS: 6US FAERS
271PolyuriaFAERS: 6US FAERS
272Prescription drug used without a prescriptionFAERS: 6US FAERS
273Product contamination physicalFAERS: 6US FAERS
274Product expiration date issueFAERS: 6US FAERS
275Product packaging issueFAERS: 6US FAERS
276Product quality control issueFAERS: 6US FAERS
277RhinitisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
278SepsisFAERS: 6US FAERS
279Sleep disorder due to a general medical conditionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
280TensionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
281Therapeutic response delayedFAERS: 6US FAERS
282Tooth LossFAERS: 6US FAERS
283Unresponsive to stimuliFAERS: 6US FAERS
284Wrong drug administeredFAERS: 6US FAERS
285Amphetamines positiveFAERS: 5US FAERS
286AnosmiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
287Aortic AneurysmFAERS: 5US FAERS
288Aphthous StomatitisFAERS: 5US FAERS
289Atypical pneumoniaFAERS: 5US FAERS
290Bronchopulmonary AspergillosisFAERS: 5US FAERS
291Carotid artery occlusionFAERS: 5US FAERS
292CystitisFAERS: 5US FAERS
293DeliriumFAERS: 5US FAERS
294Device difficult to useFAERS: 5US FAERS
295Drug abuserFAERS: 5US FAERS
296DyspepsiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
297Emergency care examinationFAERS: 5US FAERS
298FlatulenceFAERS: 5OFFSIDES
SIDER
US FAERS
299Gait inabilityFAERS: 5US FAERS
300Head discomfortFAERS: 5US FAERS
301HerniaFAERS: 5US FAERS
302HypokinesiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
303HypoventilationFAERS: 5US FAERS
304Intentional device misuseFAERS: 5US FAERS
305Intestinal ObstructionFAERS: 5US FAERS
306LethargyFAERS: 53769383CTD
US FAERS
307Limb injuryFAERS: 5US FAERS
308Lung hyperinflationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Maternal exposure during pregnancyFAERS: 5US FAERS
310Multiple allergiesFAERS: 5US FAERS
311MyoclonusFAERS: 510822452CTD
US FAERS
312NephrolithiasisFAERS: 5US FAERS
313Nonspecific reactionFAERS: 5US FAERS
314Oxygen saturation abnormalFAERS: 5US FAERS
315Oxygen supplementationFAERS: 5US FAERS
316Pericardial effusionFAERS: 5US FAERS
317PneumonitisFAERS: 5US FAERS
318Post-Traumatic Stress DisorderFAERS: 5US FAERS
319Product formulation issueFAERS: 5US FAERS
320Product prescribing errorFAERS: 5US FAERS
321Pulmonary function test decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
322Pulmonary painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
323Reaction to drug excipientsFAERS: 5US FAERS
324Sinus operationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
325Skin discomfortFAERS: 5US FAERS
326Therapeutic response unexpectedFAERS: 5US FAERS
327Accidental exposure to product by childFAERS: 4US FAERS
328AneurysmFAERS: 4US FAERS
329Atrioventricular BlockFAERS: 4US FAERS
330BedriddenFAERS: 4US FAERS
331Bipolar DisorderFAERS: 4OFFSIDES
US FAERS
332Blood immunoglobulin E increasedFAERS: 4US FAERS
333Cervix carcinomaFAERS: 4US FAERS
334Chemical burn of skinFAERS: 4US FAERS
335Circumstance or information capable of leading to device use errorFAERS: 4US FAERS
336Dental cariesFAERS: 4US FAERS
337Device use issueFAERS: 4US FAERS
338Diabetic KetoacidosisFAERS: 4US FAERS
339Drug toxicityFAERS: 4US FAERS
340Emotional disorderFAERS: 4OFFSIDES
US FAERS
341Familial Periodic ParalysisFAERS: 4US FAERS
342GlycosuriaFAERS: 4SIDER
US FAERS
343Hospice CareFAERS: 4US FAERS
344HyperthyroidismFAERS: 4US FAERS
345Incorrect storage of drugFAERS: 4US FAERS
346Initial insomniaFAERS: 4US FAERS
347Intervertebral Disc DegenerationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
348Intracranial AneurysmFAERS: 4US FAERS
349Lung cyst benignFAERS: 4US FAERS
350LymphomaFAERS: 4US FAERS
351MesotheliomaFAERS: 4US FAERS
352MydriasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
353Oral candidiasisFAERS: 4US FAERS
354Paranasal sinus polypectomyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
355Prescribed underdoseFAERS: 4US FAERS
356Product administration errorFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
357Product distribution issueFAERS: 4US FAERS
358Product leakageFAERS: 4US FAERS
359RalesFAERS: 4US FAERS
360Rash erythematousFAERS: 4US FAERS
361RegurgitationFAERS: 4US FAERS
362Rotator cuff syndromeFAERS: 4US FAERS
363SarcoidosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
364ScreamingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
365Sinus polypFAERS: 4US FAERS
366Spinal column injuryFAERS: 4US FAERS
367Spinal column stenosisFAERS: 4OFFSIDES
US FAERS
368Subcutaneous EmphysemaFAERS: 4US FAERS
369Tongue blisteringFAERS: 4US FAERS
370Troponin increasedFAERS: 4US FAERS
371Umbilical herniaFAERS: 4US FAERS
372Upper-airway cough syndromeFAERS: 4US FAERS
373VasculitisFAERS: 4US FAERS
374nervous system disorderFAERS: 4SIDER
US FAERS
375Abdominal adhesionsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
376Accidental drug intake by childFAERS: 3US FAERS
377Alcohol poisoningFAERS: 3US FAERS
378Application site burnFAERS: 3US FAERS
379Artificial crown procedureFAERS: 3US FAERS
380Bladder painFAERS: 3US FAERS
381Blood alcohol increasedFAERS: 3US FAERS
382Blood cholesterol abnormalFAERS: 3US FAERS
383Blood glucose abnormalFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
384Blood glucose decreasedFAERS: 3US FAERS
385Breast FeedingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
386Bronchial HyperreactivityFAERS: 3US FAERS
387CardiomegalyFAERS: 3US FAERS
388Clostridium difficile infectionFAERS: 3US FAERS
389Completed SuicideFAERS: 3US FAERS
390Cystic FibrosisFAERS: 3US FAERS
391Device lead damageFAERS: 3US FAERS
392Documented hypersensitivity to administered productFAERS: 3US FAERS
393DysarthriaFAERS: 3US FAERS
394Ear discomfortFAERS: 3US FAERS
395EczemaFAERS: 3SIDER
US FAERS
396Ejection Fraction DecreasedFAERS: 3US FAERS
397Electrocardiogram ST segment abnormalFAERS: 3US FAERS
398Emergency CareFAERS: 3US FAERS
399Endotracheal intubation complicationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
400Gingival RecessionFAERS: 3US FAERS
401HemiparesisFAERS: 3US FAERS
402ImmobileFAERS: 3US FAERS
403Impaired driving abilityFAERS: 3US FAERS
404Inappropriate schedule of product administrationFAERS: 3US FAERS
405Large intestine perforationFAERS: 3US FAERS
406Lower respiratory tract congestionFAERS: 3US FAERS
407Malignant neoplasm progressionFAERS: 3US FAERS
408Mouth swellingFAERS: 3US FAERS
409Mycotic allergyFAERS: 3US FAERS
410Nasal discomfortFAERS: 3US FAERS
411ObstructionFAERS: 3US FAERS
412Oral fungal infectionFAERS: 3US FAERS
413Paradoxical drug reactionFAERS: 3US FAERS
414PericarditisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
415PoisoningFAERS: 3US FAERS
416Post procedural complicationFAERS: 3US FAERS
417Product use complaintFAERS: 3US FAERS
418Product used for unknown indicationFAERS: 3US FAERS
419Prolonged expirationFAERS: 3US FAERS
420PsoriasisFAERS: 3US FAERS
421Pulmonary FibrosisFAERS: 3US FAERS
422Quality of life decreasedFAERS: 3OFFSIDES
US FAERS
423Restrictive pulmonary diseaseFAERS: 3US FAERS
424Retinal DetachmentFAERS: 3US FAERS
425Therapy cessationFAERS: 3US FAERS
426ThrombocytopeniaFAERS: 3US FAERS
427UlcerFAERS: 3US FAERS
428Urinary IncontinenceFAERS: 33769383CTD
US FAERS
429Viral upper respiratory tract infectionFAERS: 3US FAERS
430Visual disturbanceFAERS: 3US FAERS
431Walking aid userFAERS: 3OFFSIDES
US FAERS
432Wheelchair userFAERS: 3US FAERS
433Wrong patient received medicationFAERS: 3US FAERS
434treatment failureFAERS: 3US FAERS
435Abdominal strangulated herniaFAERS: 2US FAERS
436Acute Coronary SyndromeFAERS: 2US FAERS
437Adenoid Cystic CarcinomaFAERS: 2US FAERS
438Allergic sinusitisFAERS: 2US FAERS
439AnorexiaFAERS: 2OFFSIDES
SIDER
US FAERS
440Anticholinergic SyndromeFAERS: 2US FAERS
441Aortic Valve StenosisFAERS: 2US FAERS
442AphagiaFAERS: 2US FAERS
443AphasiaFAERS: 2US FAERS
444AppendicitisFAERS: 2US FAERS
445Application site erythemaFAERS: 2US FAERS
446ArteriosclerosisFAERS: 2US FAERS
447Arthropod biteFAERS: 2US FAERS
448Basal cell carcinomaFAERS: 2US FAERS
449Benign Prostatic HyperplasiaFAERS: 2US FAERS
450Blood urine presentFAERS: 2US FAERS
451BradycardiaFAERS: 2US FAERS
452Brain DeathFAERS: 2US FAERS
453Brain natriuretic peptide increasedFAERS: 2US FAERS
454Breast hyperplasiaFAERS: 2US FAERS
455Bronchial irritationFAERS: 2US FAERS
456BruxismFAERS: 2US FAERS
457CandidiasisFAERS: 2US FAERS
458Carbon dioxide increasedFAERS: 2US FAERS
459Cardiac autonomic neuropathyFAERS: 2US FAERS
460Cardiac discomfortFAERS: 2US FAERS
461Cardiac dysfunctionFAERS: 2US FAERS
462Cardiovascular insufficiencyFAERS: 2US FAERS
463Cartilage injuryFAERS: 2US FAERS
464CheilitisFAERS: 2US FAERS
465Chemical injuryFAERS: 2US FAERS
466Chronic Spontaneous UrticariaFAERS: 2US FAERS
467Colonic perforation postoperativeFAERS: 2US FAERS
468Concomitant disease aggravatedFAERS: 2US FAERS
469ConjunctivitisFAERS: 2SIDER
US FAERS
470Conversion disorderFAERS: 2US FAERS
471Cortisol decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
472Deep Vein ThrombosisFAERS: 2US FAERS
473Delayed deliveryFAERS: 2US FAERS
474DermatitisFAERS: 2SIDER
US FAERS
475Device leakageFAERS: 2US FAERS
476Diabetes mellitus inadequate controlFAERS: 2OFFSIDES
US FAERS
477DiplegiaFAERS: 2US FAERS
478Disease complicationFAERS: 2US FAERS
479Drug dose omission by deviceFAERS: 2US FAERS
480Drug resistanceFAERS: 2US FAERS
481Drug screen false positiveFAERS: 2US FAERS
482Drug withdrawal syndromeFAERS: 2US FAERS
483Dry age-related macular degenerationFAERS: 2US FAERS
484DysphemiaFAERS: 2US FAERS
485DysplasiaFAERS: 2US FAERS
486Ear congestionFAERS: 2US FAERS
487Economic problemFAERS: 2OFFSIDES
US FAERS
488Ectopic PregnancyFAERS: 2US FAERS
489EndometriosisFAERS: 2US FAERS
490EpilepsyFAERS: 2US FAERS
491Exposure via skin contactFAERS: 2US FAERS
492Eye InfectionFAERS: 2US FAERS
493Eye inflammationFAERS: 2US FAERS
494FibromatosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
495FractureFAERS: 2US FAERS
496FrustrationFAERS: 2OFFSIDES
US FAERS
497Fungal pharyngitisFAERS: 2US FAERS
498GangreneFAERS: 2OFFSIDES
US FAERS
499Gastric hypomotilityFAERS: 2US FAERS
500Gastric ulcerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
501GastritisFAERS: 2US FAERS
502GastroenteritisFAERS: 2OFFSIDES
SIDER
US FAERS
503Gestational DiabetesFAERS: 2US FAERS
504GingivitisFAERS: 2US FAERS
505GlossitisFAERS: 2SIDER
US FAERS
506Granulomatosis with polyangiitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
507HemiplegiaFAERS: 2US FAERS
508HydronephrosisFAERS: 2OFFSIDES
US FAERS
509HyperchlorhydriaFAERS: 2US FAERS
510HypersomniaFAERS: 2US FAERS
511HypervigilanceFAERS: 2US FAERS
512HysterectomyFAERS: 2US FAERS
513ImmunosuppressionFAERS: 2US FAERS
514Impaired quality of lifeFAERS: 2US FAERS
515IncoherentFAERS: 2US FAERS
516IncontinenceFAERS: 2US FAERS
517InfarctionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
518Injury associated with deviceFAERS: 2US FAERS
519Inspiratory capacity decreasedFAERS: 2US FAERS
520Intentional misuseFAERS: 2US FAERS
521Intentional self-injuryFAERS: 2US FAERS
522Intestinal PerforationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
523Intestinal metaplasiaFAERS: 2US FAERS
524Intra-abdominal fluid collectionFAERS: 2US FAERS
525Irregular breathingFAERS: 2US FAERS
526Left Ventricular HypertrophyFAERS: 2US FAERS
527Limb operationFAERS: 2US FAERS
528Live BirthFAERS: 2US FAERS
529Lower respiratory tract infection bacterialFAERS: 2US FAERS
530MastectomyFAERS: 2US FAERS
531Medical induction of comaFAERS: 2US FAERS
532Microbiology test abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
533Muscle tightnessFAERS: 2OFFSIDES
US FAERS
534Myotonic DystrophyFAERS: 2US FAERS
535NecrosisFAERS: 2US FAERS
536Nerve injuryFAERS: 2US FAERS
537ObesityFAERS: 2US FAERS
538Oral mucosal exfoliationFAERS: 2US FAERS
539Oropharyngeal discomfortFAERS: 2US FAERS
540Oropharyngeal swellingFAERS: 2SIDER
US FAERS
541OsteomyelitisFAERS: 2OFFSIDES
US FAERS
542OsteopeniaFAERS: 2US FAERS
543Oxygen consumption decreasedFAERS: 2US FAERS
544Pancreatic carcinomaFAERS: 2US FAERS
545Paranasal biopsyFAERS: 2US FAERS
546ParanoiaFAERS: 2US FAERS
547Peptic UlcerFAERS: 2US FAERS
548Peripheral arthritisFAERS: 2US FAERS
549PhimosisFAERS: 2US FAERS
550Post procedural infectionFAERS: 2OFFSIDES
US FAERS
551Postoperative ileusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
552Precancerous cells presentFAERS: 2US FAERS
553Procedural complicationFAERS: 2US FAERS
554Product coating issueFAERS: 2US FAERS
555Product design confusionFAERS: 2US FAERS
556Product design issueFAERS: 2US FAERS
557Product dosage form issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
558Product impurityFAERS: 2US FAERS
559Product measured potency issueFAERS: 2US FAERS
560Product outer packaging issueFAERS: 2US FAERS
561Product physical consistency issueFAERS: 2US FAERS
562Psychiatric symptomFAERS: 2US FAERS
563Pulmonary thrombosisFAERS: 2US FAERS
564PyelonephritisFAERS: 2US FAERS
565Rehabilitation therapyFAERS: 2US FAERS
566Respiratory complication associated with deviceFAERS: 2US FAERS
567Restless Legs SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
568Root canal infectionFAERS: 2US FAERS
569ScabFAERS: 2US FAERS
570Self-induced vomitingFAERS: 2US FAERS
571Serotonin SyndromeFAERS: 2US FAERS
572Single functional kidneyFAERS: 2US FAERS
573Sinus headacheFAERS: 2US FAERS
574Sinusitis aspergillusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
575Sjogren's SyndromeFAERS: 2US FAERS
576Sputum retentionFAERS: 2US FAERS
577Status EpilepticusFAERS: 2US FAERS
578Stevens-Johnson SyndromeFAERS: 2US FAERS
579StridorFAERS: 2US FAERS
580Sudden deathFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
581SuperinfectionFAERS: 2US FAERS
582TachyphreniaFAERS: 2US FAERS
583Therapeutic product effect decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
584Therapeutic response changedFAERS: 2
Canada Vigilance: 4
Canada Vigilance
US FAERS
585ThirstFAERS: 2US FAERS
586ThymomaFAERS: 2US FAERS
587ThyroidectomyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
588Thyrotoxic periodic paralysisFAERS: 2US FAERS
589ToothacheFAERS: 2US FAERS
590Total lung capacity abnormalFAERS: 2US FAERS
591Tracheal painFAERS: 2US FAERS
592Troponin I increasedFAERS: 2US FAERS
593Urine alcohol test positiveFAERS: 2US FAERS
594Victim of homicideFAERS: 2US FAERS
595Vitamin D DeficiencyFAERS: 2US FAERS
596Vulvovaginal pruritusFAERS: 2US FAERS
597White blood cell count decreasedFAERS: 2US FAERS
598cancer surgeryFAERS: 2US FAERS
599furuncleFAERS: 2OFFSIDES
US FAERS
600skin abrasionFAERS: 2US FAERS
601Abdominal hernia gangrenousFAERS: 1US FAERS
602Abdominal rigidityFAERS: 1US FAERS
603Abnormal sleep-related eventFAERS: 1US FAERS
604Abnormal weight gainFAERS: 1US FAERS
605AbscessFAERS: 1US FAERS
606Accidental device ingestionFAERS: 1US FAERS
607Accidental exposure to product packagingFAERS: 1US FAERS
608AcidosisFAERS: 13769383CTD
US FAERS
609AcneFAERS: 1US FAERS
610Acute sinusitisFAERS: 1US FAERS
611AgoraphobiaFAERS: 1US FAERS
612AlbuminuriaFAERS: 1US FAERS
613Alcohol abuseFAERS: 1US FAERS
614Allergy to chemicalsFAERS: 1US FAERS
615Altered state of consciousnessFAERS: 1US FAERS
616AmblyopiaFAERS: 1US FAERS
617Angle Closure GlaucomaFAERS: 1US FAERS
618Animal scratchFAERS: 1US FAERS
619AnoxiaFAERS: 1US FAERS
620Aortic occlusionFAERS: 1US FAERS
621Application site necrosisFAERS: 1US FAERS
622Application site painFAERS: 1US FAERS
623Application site vesiclesFAERS: 1US FAERS
624Arthropod stingFAERS: 1US FAERS
625Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
626AsterixisFAERS: 1US FAERS
627AsthenopiaFAERS: 1US FAERS
628AstigmatismFAERS: 1US FAERS
629Autonomic nervous system imbalanceFAERS: 1US FAERS
630BacteriuriaFAERS: 1US FAERS
631Bladder neck obstructionFAERS: 1US FAERS
632Bladder prolapseFAERS: 1US FAERS
633BlepharitisFAERS: 1US FAERS
634BlepharochalasisFAERS: 1US FAERS
635BlepharospasmFAERS: 1OFFSIDES
US FAERS
636Blood albumin decreasedFAERS: 1US FAERS
637Blood albumin increasedFAERS: 1US FAERS
638Blood calcium abnormalFAERS: 1OFFSIDES
US FAERS
639Blood creatine phosphokinase increasedFAERS: 1US FAERS
640Blood immunoglobulin E abnormalFAERS: 1US FAERS
641Blood pH increasedFAERS: 1US FAERS
642Blood potassium increasedFAERS: 1US FAERS
643Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
644Bone abscessFAERS: 1US FAERS
645Borderline glaucomaFAERS: 1US FAERS
646Breathing-related sleep disorderFAERS: 1US FAERS
647Breech PresentationFAERS: 1US FAERS
648Bronchial secretion retentionFAERS: 1US FAERS
649Burn infectionFAERS: 1US FAERS
650BursitisFAERS: 1US FAERS
651Carbon Monoxide PoisoningFAERS: 1US FAERS
652Cardiac FlutterFAERS: 1OFFSIDES
US FAERS
653Cardiac assistance device userFAERS: 1US FAERS
654Cardiac ventriculogram left abnormalFAERS: 1US FAERS
655Cavernous Sinus ThrombosisFAERS: 1US FAERS
656Cerebral ThrombosisFAERS: 1US FAERS
657Cerebral congestionFAERS: 1US FAERS
658Cholecystitis infectiveFAERS: 1US FAERS
659CholecystitisFAERS: 1OFFSIDES
US FAERS
660CholestasisFAERS: 1US FAERS
661Chronic respiratory failureFAERS: 1US FAERS
662ClaustrophobiaFAERS: 1US FAERS
663Cleft PalateFAERS: 1US FAERS
664Clostridium difficile colitisFAERS: 1US FAERS
665Cognitive deteriorationFAERS: 1US FAERS
666ColitisFAERS: 1OFFSIDES
US FAERS
667Complex partial seizuresFAERS: 1US FAERS
668Complication associated with deviceFAERS: 1US FAERS
669Consciousness fluctuatingFAERS: 1US FAERS
670Croup infectiousFAERS: 1US FAERS
671Culture urine positiveFAERS: 1US FAERS
672CystFAERS: 1US FAERS
673Dependence on oxygen therapyFAERS: 1US FAERS
674Device damageFAERS: 1US FAERS
675Device primingFAERS: 1US FAERS
676Device related infectionFAERS: 1US FAERS
677Diabetes InsipidusFAERS: 1US FAERS
678Diastolic dysfunctionFAERS: 1US FAERS
679Disease susceptibilityFAERS: 1US FAERS
680Diverticular perforationFAERS: 1US FAERS
681Documented hypersensitivity to administered drugFAERS: 1US FAERS
682Drug administered in wrong deviceFAERS: 1US FAERS
683Drug dispensed to wrong patientFAERS: 1US FAERS
684Drug effect faster than expectedFAERS: 1US FAERS
685Drug effect variableFAERS: 1US FAERS
686Drug level below therapeuticFAERS: 1US FAERS
687Drug level changedFAERS: 1US FAERS
688Drug level increasedFAERS: 1US FAERS
689Dry lung syndromeFAERS: 1US FAERS
690Dry skinFAERS: 1OFFSIDES
US FAERS
691DyslexiaFAERS: 1US FAERS
692Dyspnoea exacerbatedFAERS: 1US FAERS
693DystoniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
694Electromechanical dissociationFAERS: 1US FAERS
695Enamel anomalyFAERS: 1US FAERS
696Environmental ExposureFAERS: 1US FAERS
697EosinophiliaFAERS: 1US FAERS
698Eosinophilic bronchitisFAERS: 1US FAERS
699Erectile dysfunctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
700ExophthalmosFAERS: 1US FAERS
701Exposure to allergenFAERS: 1US FAERS
702Exposure to chemical pollutionFAERS: 1US FAERS
703Exposure via contaminated deviceFAERS: 1US FAERS
704Exposure via direct contactFAERS: 1US FAERS
705Exposure via eye contactFAERS: 1US FAERS
706Exposure via inhalationFAERS: 1US FAERS
707Eye BurnsFAERS: 1US FAERS
708Eye RednessFAERS: 1US FAERS
709Facial paralysisFAERS: 1US FAERS
710Failure of implantFAERS: 1US FAERS
711False positive investigation resultFAERS: 1US FAERS
712False positive laboratory resultFAERS: 1US FAERS
713Feeding tube userFAERS: 1US FAERS
714Feelings of worthlessnessFAERS: 1US FAERS
715Flank PainFAERS: 1US FAERS
716Forced expiratory volume increasedFAERS: 1US FAERS
717GastrectomyFAERS: 1US FAERS
718Gastrointestinal inflammationFAERS: 1US FAERS
719Gaze palsyFAERS: 1US FAERS
720General physical condition abnormalFAERS: 1US FAERS
721Genital rashFAERS: 1OFFSIDES
US FAERS
722Gingival erythemaFAERS: 1US FAERS
723Grip strength decreasedFAERS: 1US FAERS
724Growth retardationFAERS: 1US FAERS
725Guillain-Barre SyndromeFAERS: 1US FAERS
726Hand-Arm Vibration SyndromeFAERS: 1US FAERS
727Heart sounds abnormalFAERS: 1US FAERS
728Hepatitis CFAERS: 1US FAERS
729HepatomegalyFAERS: 1US FAERS
730HepatotoxicityFAERS: 1US FAERS
731Hip surgeryFAERS: 1US FAERS
732HoarsenessFAERS: 1SIDER
US FAERS
733HydrocephalusFAERS: 1US FAERS
734HyperacusisFAERS: 1US FAERS
735HyperkeratosisFAERS: 1OFFSIDES
US FAERS
736HyperoxiaFAERS: 1US FAERS
737HyperpyrexiaFAERS: 1US FAERS
738Hypertensive crisisFAERS: 1US FAERS
739Hypertrophy of tongue papillaeFAERS: 1US FAERS
740Hypoaesthesia facialFAERS: 1US FAERS
741HypophagiaFAERS: 1OFFSIDES
US FAERS
742Iatrogenic injuryFAERS: 1US FAERS
743Impaired gastric emptyingFAERS: 1US FAERS
744Inadequate aseptic technique in use of productFAERS: 1US FAERS
745Inappropriate PrescribingFAERS: 1US FAERS
746Inappropriate affectFAERS: 1US FAERS
747Inappropriate release of product for distributionFAERS: 1US FAERS
748Incorrect drug dosage form administeredFAERS: 1US FAERS
749Incorrect product formulation administeredFAERS: 1US FAERS
750Increased tendency to bruiseFAERS: 1US FAERS
751Increased viscosity of bronchial secretionFAERS: 1US FAERS
752Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
753Infantile apnoeic attackFAERS: 1US FAERS
754Infective exacerbation of chronic obstructive airways diseaseFAERS: 1US FAERS
755InflammationFAERS: 1SIDER
US FAERS
756InjectionFAERS: 1US FAERS
757Intentional dose omissionFAERS: 1US FAERS
758Intentional misuse of drug delivery systemFAERS: 1US FAERS
759Intercepted drug dispensing errorFAERS: 1US FAERS
760Intervertebral disc disorderFAERS: 1OFFSIDES
US FAERS
761Intraocular pressure test abnormalFAERS: 1US FAERS
762IntussusceptionFAERS: 1US FAERS
763KetonuriaFAERS: 1US FAERS
764Labile blood pressureFAERS: 1US FAERS
765Lack of spontaneous speechFAERS: 1US FAERS
766Laryngitis fungalFAERS: 1US FAERS
767Leukocytoclastic vasculitisFAERS: 1US FAERS
768Libido disorderFAERS: 1US FAERS
769Limb crushing injuryFAERS: 1US FAERS
770Limb discomfortFAERS: 1OFFSIDES
US FAERS
771Lip pruritusFAERS: 1US FAERS
772Liquid product physical issueFAERS: 1US FAERS
773Livedo ReticularisFAERS: 1OFFSIDES
US FAERS
774Locked-In SyndromeFAERS: 1US FAERS
775Lower respiratory tract infection viralFAERS: 1US FAERS
776Lyme DiseaseFAERS: 1US FAERS
777MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
778Manufacturing issueFAERS: 1US FAERS
779Mastication disorderFAERS: 1US FAERS
780MeaslesFAERS: 1US FAERS
781Meniscus injuryFAERS: 1US FAERS
782Micturition frequency decreasedFAERS: 1US FAERS
783Milk AllergyFAERS: 1US FAERS
784Mononucleosis syndromeFAERS: 1US FAERS
785MonoplegiaFAERS: 1US FAERS
786Multiple Chemical SensitivityFAERS: 1US FAERS
787Multiple drug overdose intentionalFAERS: 1US FAERS
788Multiple drug therapyFAERS: 1US FAERS
789Muscle RigidityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
790Muscle SpasticityFAERS: 1US FAERS
791Muscle strainFAERS: 1US FAERS
792Muscular DystrophyFAERS: 1US FAERS
793Myocardial bridgingFAERS: 1US FAERS
794Nasal FlaringFAERS: 1US FAERS
795Neutrophil percentage increasedFAERS: 1US FAERS
796Nipple painFAERS: 1US FAERS
797No adverse effectFAERS: 1US FAERS
798No reaction on previous exposure to drugFAERS: 1US FAERS
799NocturiaFAERS: 1US FAERS
800NoduleFAERS: 1US FAERS
801Obsessive-Compulsive DisorderFAERS: 1US FAERS
802Occupational exposure to air contaminantsFAERS: 1US FAERS
803Occupational exposure to dustFAERS: 1US FAERS
804Ocular discomfortFAERS: 1US FAERS
805OligohydramniosFAERS: 1US FAERS
806Oncologic complicationFAERS: 1US FAERS
807OnychomycosisFAERS: 1US FAERS
808Opiates positiveFAERS: 1US FAERS
809Oral administration complicationFAERS: 1US FAERS
810Oral mucosal eruptionFAERS: 1US FAERS
811Oral mucosal erythemaFAERS: 1US FAERS
812Oral pruritusFAERS: 1US FAERS
813Oropharyngeal candidiasisFAERS: 1US FAERS
814Orthosis userFAERS: 1US FAERS
815Otitis MediaFAERS: 1SIDER
US FAERS
816Oxygen ConsumptionFAERS: 1US FAERS
817Pancreatic NeoplasmFAERS: 1US FAERS
818PancreatitisFAERS: 1OFFSIDES
US FAERS
819Panic DisorderFAERS: 1US FAERS
820Performance status decreasedFAERS: 1US FAERS
821Perineal painFAERS: 1US FAERS
822Periodontal infectionFAERS: 1US FAERS
823PeriodontitisFAERS: 1OFFSIDES
US FAERS
824Peripheral arterial occlusive diseaseFAERS: 1US FAERS
825Peripheral artery occlusionFAERS: 1US FAERS
826PeritonitisFAERS: 1OFFSIDES
US FAERS
827Pertussis identification test positiveFAERS: 1US FAERS
828PertussisFAERS: 1US FAERS
829PetechiaeFAERS: 1US FAERS
830Pharyngeal swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
831PhotophobiaFAERS: 1US FAERS
832Pituitary cystFAERS: 1US FAERS
833PneumonectomyFAERS: 1US FAERS
834PolyneuropathyFAERS: 1US FAERS
835Poor peripheral circulationFAERS: 1US FAERS
836Pre-existing condition improvedFAERS: 1US FAERS
837Prescription form tamperingFAERS: 1US FAERS
838Product administered to patient of inappropriate ageFAERS: 1US FAERS
839Product counterfeitFAERS: 1US FAERS
840Product depositFAERS: 1US FAERS
841Product dispensing errorFAERS: 1US FAERS
842Product preparation errorFAERS: 1US FAERS
843Product prescribing issueFAERS: 1US FAERS
844Product residue presentFAERS: 1US FAERS
845Protein S DeficiencyFAERS: 1US FAERS
846ProteinuriaFAERS: 1US FAERS
847Pruritus allergicFAERS: 1US FAERS
848Pseudomonas test positiveFAERS: 1US FAERS
849Psychological TraumaFAERS: 1US FAERS
850PurulenceFAERS: 1US FAERS
851QRS axis abnormalFAERS: 1US FAERS
852QuadriplegiaFAERS: 1US FAERS
853Radiation skin injuryFAERS: 1US FAERS
854Rectal ProlapseFAERS: 1US FAERS
855Respiratory DepressionFAERS: 1US FAERS
856Respiratory tract infection bacterialFAERS: 1US FAERS
857Respiratory tract infection viralFAERS: 1US FAERS
858Resting TremorFAERS: 1US FAERS
859Retinal Artery OcclusionFAERS: 1US FAERS
860RetinoschisisFAERS: 1US FAERS
861SacroiliitisFAERS: 1US FAERS
862SarcomaFAERS: 1US FAERS
863Semen volume decreasedFAERS: 1US FAERS
864Senile dementiaFAERS: 1US FAERS
865Sensitivity to weather changeFAERS: 1US FAERS
866SialometaplasiaFAERS: 1US FAERS
867Skeletal injuryFAERS: 1US FAERS
868Skin UlcerFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
869Skin WrinklingFAERS: 1US FAERS
870Skin irritationFAERS: 1US FAERS
871Skin lesionFAERS: 1US FAERS
872Small cell lung cancer metastaticFAERS: 1US FAERS
873Spinal StenosisFAERS: 1US FAERS
874Squamous cell carcinomaFAERS: 1US FAERS
875StarvationFAERS: 1US FAERS
876Status AsthmaticusFAERS: 1114264
7427548
CTD
US FAERS
877Strangulated herniaFAERS: 1US FAERS
878Subclavian artery occlusionFAERS: 1US FAERS
879Sudden onset of sleepFAERS: 1US FAERS
880SunburnFAERS: 1US FAERS
881Suspected counterfeit productFAERS: 1US FAERS
882Systolic hypertensionFAERS: 1US FAERS
883TachyphylaxisFAERS: 1US FAERS
884Tardive DyskinesiaFAERS: 1OFFSIDES
US FAERS
885Terminal stateFAERS: 1US FAERS
886Therapeutic reaction time decreasedFAERS: 1US FAERS
887Therapy non-responderFAERS: 1US FAERS
888Thoracic vertebral fractureFAERS: 1OFFSIDES
US FAERS
889Throat clearingFAERS: 1US FAERS
890Thyroid NeoplasmFAERS: 1US FAERS
891Tinea PedisFAERS: 1US FAERS
892Tobacco userFAERS: 1US FAERS
893Tongue bitingFAERS: 1US FAERS
894Tonic clonic movementsFAERS: 1US FAERS
895TonsillitisFAERS: 1OFFSIDES
US FAERS
896Tooth ErosionFAERS: 1OFFSIDES
US FAERS
897Tooth ExtractionFAERS: 1US FAERS
898Toxic Epidermal NecrolysisFAERS: 1US FAERS
899TrichorrhexisFAERS: 1US FAERS
900UnemploymentFAERS: 1US FAERS
901Unilateral bronchospasmFAERS: 1US FAERS
902Upper airway obstructionFAERS: 1US FAERS
903Upper respiratory tract congestionFAERS: 1US FAERS
904Urinary hesitationFAERS: 1US FAERS
905Urine amphetamine positiveFAERS: 1US FAERS
906Uterine CancerFAERS: 1US FAERS
907Uterine ProlapseFAERS: 1US FAERS
908Ventricular hypokinesiaFAERS: 1US FAERS
909Vertebral Artery DissectionFAERS: 1US FAERS
910Vitreous floatersFAERS: 1US FAERS
911Vulvovaginal burning sensationFAERS: 1US FAERS
912Walking distance test abnormalFAERS: 1US FAERS
913Wound ComplicationFAERS: 1US FAERS
914intensive careFAERS: 1US FAERS
915Abdominal bloatingSIDER
916Acid refluxOFFSIDES
917Acute kidney injury2870244CTD
918AgraphiaOFFSIDES
919AkinesiaCanada Vigilance: 1Canada Vigilance
920Altered bowel functionOFFSIDES
921AlveolitisOFFSIDES
922Ammonia increasedOFFSIDES
923AmputationOFFSIDES
924Anal FissureOFFSIDES
925AnhedoniaOFFSIDES
926Anoxic EncephalopathyOFFSIDES
927ApathyOFFSIDES
928Application site reactionSIDER
929Arthritis, Experimental10229875CTD
930AtaxiaCanada Vigilance: 1Canada Vigilance
SIDER
931AtelectasisOFFSIDES
932AtherosclerosisOFFSIDES
933Atrial Premature Complexes2462383CTD
934Atrial tachycardiaOFFSIDES
935AuraOFFSIDES
936Autoimmune inner ear diseaseOFFSIDES
937Autonomic neuropathySIDER
938Biliary dilatationOFFSIDES
939Blood GlucoseOFFSIDES
940Blood sodium increasedOFFSIDES
941Blood sodiumOFFSIDES
942Blood triglycerides increasedOFFSIDES
943Blurred visionOFFSIDES
944Bone density decreasedOFFSIDES
945Bronchitis, Chronic3311117CTD
946Bronchospasm aggravatedSIDER
947Capillary FragilityOFFSIDES
948Cardiomyopathies6625250CTD
949Cardiomyopathy, Dilated19081299CTD
950Carotid bruitOFFSIDES
951Central line infectionOFFSIDES
952Cerebellar infarctionOFFSIDES
953Cervical dysplasiaOFFSIDES
954Cervicobrachial syndromeOFFSIDES
955Chronic Obstructive Airway DiseaseOFFSIDES
956Clostridium colitisOFFSIDES
957Cold symptomsSIDER
958Compression fractureOFFSIDES
959Compulsive shoppingOFFSIDES
960ConfabulationOFFSIDES
961Confusion3769383CTD
962Continuous Positive Airway PressureOFFSIDES
963Cramps of lower extremitiesSIDER
964Culture positiveOFFSIDES
965DemyelinationOFFSIDES
966Dental abscessOFFSIDES
967DiabetesOFFSIDES
968Diabetic NephropathyOFFSIDES
969Diaphragmatic HerniaOFFSIDES
970DiarrheaOFFSIDES
971DiverticulumOFFSIDES
972DrowsinessSIDER
973Drug withdrawal headacheOFFSIDES
974DuodenitisOFFSIDES
975DyspareuniaOFFSIDES
976Dyspnea12970051
20016425
CTD
977Dysthymic DisorderOFFSIDES
978Electrocardiogram abnormalSIDER
979Electrocardiogram changeSIDER
980Embolic strokeOFFSIDES
981EncephalomalaciaOFFSIDES
982Epigastric distressSIDER
983Epigastric painSIDER
984EructationSIDER
985Exacerbation of asthmaSIDER
986Extremity necrosisOFFSIDES
987Febrile NeutropeniaOFFSIDES
988Feeling tenseSIDER
989Fibrosis15467267CTD
990Fluid overloadSIDER
991FormicationOFFSIDES
992GaggingSIDER
993GamblingOFFSIDES
994GammopathyOFFSIDES
995Gas Poisoning20016425CTD
996Gastrointestinal PainSIDER
997GranulocytosisOFFSIDES
998Heart failure

View details

CTD
999HeartburnSIDER
1000Heparin-induced thrombocytopeniaOFFSIDES
1001Hepatic congestionOFFSIDES
1002HordeolumOFFSIDES
1003HostilityOFFSIDES
1004Human papilloma virus test positiveOFFSIDES
1005Hyperglycemia

View details

CTD
1006Hyperinsulinism8098220CTD
1007Hyperkalemia2384735
6114774
CTD
1008HyperkinesiaSIDER
1009Hypertensive heart diseaseOFFSIDES
1010Hypoglycemia15232249CTD
1011Hypokalemia

View details

CTD
1012Hypotension, Orthostatic6476995CTD
1013IleusSIDER
1014Implant site infectionOFFSIDES
1015Infusion site mobility decreasedOFFSIDES
1016Intention tremorOFFSIDES
1017Joint InstabilityOFFSIDES
1018Joint Range of Motion DecreasedOFFSIDES
1019Joint stiffnessOFFSIDES
1020KeratitisCanada Vigilance: 1Canada Vigilance
1021KetosisSIDER
1022Kidney Diseases16428940CTD
1023Kidney Failure, Chronic2384735CTD
1024Kidney FailureOFFSIDES
1025LaryngospasmOFFSIDES
1026LichenificationOFFSIDES
1027LightheadednessSIDER
1028Long QT Syndrome9244742CTD
1029Loop electrosurgical excision procedureOFFSIDES
1030Lung Diseases, Obstructive2462383CTD
1031Lung diseases14984458CTD
1032MalnutritionSIDER
1033MastoiditisOFFSIDES
1034Mechanical urticariaOFFSIDES
1035Medical device removalOFFSIDES
1036Mental status changesOFFSIDES
1037Mesenteric vascular insufficiencyOFFSIDES
1038MetatarsalgiaOFFSIDES
1039Mood swingsSIDER
1040Multi-organ disorderOFFSIDES
1041Multiple PregnancySIDER
1042Muscle Cramp698761CTD
1043Muscle WeaknessOFFSIDES
1044Muscle fibrosisOFFSIDES
1045Myocardial Ischemia90996
15699818
CTD
1046Myocarditis16908771CTD
1047Nephrogenic Fibrosing DermopathyOFFSIDES
1048Neutropenic colitisOFFSIDES
1049Neutropenic sepsisOFFSIDES
1050OrthopneaOFFSIDES
1051Paresis18412527CTD
1052Penile swellingOFFSIDES
1053Peripheral embolismOFFSIDES
1054Peripheral occlusive diseaseOFFSIDES
1055Peripheral vasodilatationSIDER
1056Physical disabilityOFFSIDES
1057PlatybasiaOFFSIDES
1058Post procedural pneumoniaOFFSIDES
1059Pre-EclampsiaSIDER
1060Protein C DeficiencyOFFSIDES
1061PyuriaOFFSIDES
1062Radiation associated painOFFSIDES
1063Radical hysterectomyOFFSIDES
1064RadiculitisOFFSIDES
1065Rectal fissureOFFSIDES
1066Reflux gastritisOFFSIDES
1067Renal cystOFFSIDES
1068Renal tubular necrosisOFFSIDES
1069Respiratory Sounds9166355
16101941
CTD
1070Respiratory Tract Infections16205517CTD
1071RhonchiOFFSIDES
1072Risus sardonicusOFFSIDES
1073Saliva alteredSIDER
1074SchizophreniaOFFSIDES
1075Seizures9190242CTD
1076Self MutilationOFFSIDES
1077Sensation of warmthSIDER
1078Septic ShockOFFSIDES
1079Silent myocardial infarctionOFFSIDES
1080Skin IndurationOFFSIDES
1081Skin hypertrophyOFFSIDES
1082Skin tightnessOFFSIDES
1083Soft Tissue InjuriesOFFSIDES
1084Spasm8680739CTD
1085Stomach acheSIDER
1086Subcutaneous noduleOFFSIDES
1087Sudden Cardiac DeathOFFSIDES
1088SweatingSIDER
1089Tachycardia, Ventricular3984838CTD
1090Temporal ArteritisOFFSIDES
1091Tongue discomfortCanada Vigilance: 1Canada Vigilance
1092TracheitisSIDER
1093Tremor of handsSIDER
1094Urination Disorders18225795CTD
1095Vasodilation procedureSIDER
1096VasodilationSIDER
1097Venoocclusive diseaseOFFSIDES
1098Ventricular Dysfunction, Left2364580
6706438
CTD
1099Ventricular Outflow Obstruction12970051CTD
1100Vitamin K DeficiencyOFFSIDES
1101Vocal Cord ParalysisOFFSIDES
1102Vulvovaginal mycotic infectionSIDER
1103Weight GainOFFSIDES
1104Wound infection staphylococcalOFFSIDES
1105anaphylaxis12637407
16101941
CTD
1106jaundiceSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.